Paul Tudor Jones’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Paul Tudor Jones’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,294	Closed	-$757K	–	3016
2023 Q2	$757K	Sell	16,294 -13,392	-45%	-$463K	0.01%	1474
2023 Q1	$851K	Buy	+29,686	New	+$879K	0.01%	1297
2022 Q3	–	Sell	-12,369	Closed	-$192K	–	2827
2022 Q2	$192K	Buy	12,369 +1,300	+12%	+$22.4K	0.01%	1834
2022 Q1	$212K	Sell	11,069 -1,300	-11%	-$23.2K	0.01%	1738
2021 Q4	$313K	Sell	12,369 -71,601	-85%	-$2.1M	0.01%	1810
2021 Q3	$2.75M	Buy	+83,970	New	+$2.86M	0.04%	530

Paul Tudor Jones's DICE Position: Q3 2023 in Review

Paul Tudor Jones sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 16,294 shares — an estimated $757K sold.

Paul Tudor Jones first reported a position in DICE in Q3 2021 and held it in 6 quarters. The position peaked at $2.75M in Q3 2021. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Paul Tudor Jones reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Paul Tudor Jones sold 16,294 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $757K.
Paul Tudor Jones first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
Paul Tudor Jones's DICE Therapeutics, Inc. Common Stock position peaked at $2.75M in Q3 2021.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Tudor Investment Corp's 13F filing for Q3 2023, filed 15 Nov 2023.